Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No. That is not right. It’s probably a lot more by now. Question really is,
Is this merger real or just to sell all these shares
Only 257,507,081 Unrestricted Shares here? Is that right? 12/12/2023
https://www.otcmarkets.com/stock/CSTF/security
decent day held up well if it breaks .001 again tomorrow chance for .0012s
I wonder how Dec sales went..Maybe we get an update?
Man you are greedy..10 mil at .0009?. Let it run into the close.
Big move today....continuation tomorrow....
Loaded 8's ready for the upward $$$CSTF$$$
Domiciliary Merger: On November 8, 2022, the predecessor issuer, Curascientific Corp. of Florida (“CSFL”), completed a domiciliary merger into Curascientific Corp. of Oklahoma formed on December 11, 2023 (“CuraA”), with that Oklahoma company being the survivor.
https://www.otcmarkets.com/filing/html?id=17155155&guid=ZtJ-kKBvVFdqJth
Honestly, Achieving another 150% requires more than just Reena's desire for it.
Do u see it going to 003?
Wow looks like SPZI 2.0 here amazing MERGER news today in the 8k!
Hmm... Considering the pending merger news, it appears I might have been wise to retain all my shares. Let's observe how this situation unfolds.
I took a few not ready to slap as hard as my entry
9’s up and THIN!!!!
Yes especially for 15 minutes. Free shares already.
Gonna move higher with big Twitter pumpers in it!!!! WEEEEEEE!!!!
WOW!!!! NICE MOVE TODAY!!! Congratulations everyone that loaded the lows!!!!
dilution at its finest... its been going on for a while already.
It will pop for a day or two, but then it'll dive again. Rinse and Repeat as they say!
well they filed and there has been some resignations. I wonder what kind of mumbo jumbo news is gonna come out next with this company!
from NT 10-Q filed on 10-14-2023:
this is the 2nd stock im following that this has happened to this week!!!! I just loaded more on a couple different ones today, but not here since they are in the weed business.
GLTY!!
It's the OTC coming back! No news rallies were the start of 2021 OTC melt-up!
what is going on here????? big buys coming through finally!
its on its way..... I doubt it will last though
$CSTF- way undervalued imo. I’m expecting .005/.012 soon.
Has anyone talked to anyone at the " company ", I've left 4 messages and no response. So sad 😞
over 2.3 billion shares added to the Outstanding Share count, which most of them are Restricted...... the only reason I see why this happened is because the market cap (company value) skyrocketed from $350k to over $5.7 million.
Crazy manipulation going on, especially when there are no disclosures filed as to why the Restricted Share increase!!!!
that is my opinion
Well the Shorts are turning the lights off. So much for a turn around. Same old POS with a new name.
Seems like Reed isn’t helping much to turn things around. Same old bs with a new name.
[-chart]www.stockscores.com/chart.asp?TickerSymbol=CSTF&TimeRange=275&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=BBW&Indicator3=AccDist&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]
The ultimate trifecta Shitz shamorama crap on all gullible buyers..
yet on Quarterly Reports and Annual Report published after it shows revenue of $34k.... 3 Quarters went by and we barely had a tenth of "expected" daily sales.
9 months of Revenue was $34,434.
9 months of "expected" Revenue (per PR) was $58 million.
But wait, CSTF is negotiating a $150 million contract right now!!!!!!!!!!!!!!!
SMH
Boon’s Processing Facility Up and Running $78M Annual Capacity
Press Release | 03/17/2022
Boon's production facility is complete and sees an increase in new orders as a result of its newly certified Good Manufacturing Practices
SACRAMENTO, CA, March 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an environmentally conscious bioscience company delivering solutions that benefit people and the planet, is pleased to announce that its production facility is complete, and an increase in new orders as a result of its newly certified Good Manufacturing Practice (cGMP) status for its production facility in Grass Valley.
Justin Gonzalez, Chairman, stated, “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required. BioDox is bottled in a concentrated formula that is sold by the quart for $89 or by the gallon for $229.“
This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres.
Mr. Gonzalez further stated, “The agriculture markets allow Boon to generate sales as a 25(b) product while waiting for EPA approval for other applications, and Boon is currently developing sales in these markets. We believe our current success in the agriculture industry will be relative to the pending EPA compliant industries such as medical, hospitality and warehousing that as the Company accomplishes these compliance milestones we will continue to see an increase of revenue from larger distributors for our products as we expand into new markets.”
About Boon Industries
Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon’s product offering is DiOx+™ and BioDox™ , a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind Boon’s products make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. BioDox™ helps prevent agricultural crops from disease. Diox+™ is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon’s CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California.
That’s huge!!!!!!
300.000 rev.per day!!!!!
Ask the "CEO" where’s the truth.
Ask the SEC why the "CEO“ isn’t in jail.
Ask Batman why the "SEC" and the "CEO“
aren’t there where they belong too.
Yeah
Boon’s Processing Facility Up and Running $78M Annual Capacity
Press Release | 03/17/2022
Boon's production facility is complete and sees an increase in new orders as a result of its newly certified Good Manufacturing Practices
SACRAMENTO, CA, March 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an environmentally conscious bioscience company delivering solutions that benefit people and the planet, is pleased to announce that its production facility is complete, and an increase in new orders as a result of its newly certified Good Manufacturing Practice (cGMP) status for its production facility in Grass Valley.
Justin Gonzalez, Chairman, stated, “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required. BioDox is bottled in a concentrated formula that is sold by the quart for $89 or by the gallon for $229.“
This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres.
Mr. Gonzalez further stated, “The agriculture markets allow Boon to generate sales as a 25(b) product while waiting for EPA approval for other applications, and Boon is currently developing sales in these markets. We believe our current success in the agriculture industry will be relative to the pending EPA compliant industries such as medical, hospitality and warehousing that as the Company accomplishes these compliance milestones we will continue to see an increase of revenue from larger distributors for our products as we expand into new markets.”
About Boon Industries
Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon’s product offering is DiOx+™ and BioDox™ , a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind Boon’s products make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. BioDox™ helps prevent agricultural crops from disease. Diox+™ is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon’s CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California.
Followers
|
290
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31824
|
Created
|
08/16/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |